126 related articles for article (PubMed ID: 25302081)
21. Association between PPARGC1A single nucleotide polymorphisms and increased risk of nonalcoholic fatty liver disease among Iranian patients with type 2 diabetes mellitus.
Saremi L; Lotfıpanah S; Mohammadi M; Hosseinzadeh H; Hosseini-Khah Z; Johari B; Saltanatpour Z
Turk J Med Sci; 2019 Aug; 49(4):1089-1094. PubMed ID: 31390852
[TBL] [Abstract][Full Text] [Related]
22. Effect of Peroxisome Proliferator-Activated Receptor-γ Coactivator-1 Alpha Variants on Spontaneous Clearance and Fibrosis Progression during Hepatitis C Virus Infection in Moroccan Patients.
ElFihry R; Elmessaoudi-Idrissi M; Jadid FZ; Zaidane I; Chihab H; Tahiri M; Kabine M; Badre W; Chemin I; Marchio A; Pineau P; Ezzikouri S; Benjelloun S
Virol Sin; 2020 Oct; 35(5):566-574. PubMed ID: 32297157
[TBL] [Abstract][Full Text] [Related]
23. Polymorphisms of the peroxisome proliferator-activated receptor-γ (rs1801282) and its coactivator-1 (rs8192673) are associated with obesity indexes in subjects with type 2 diabetes mellitus.
Kruzliak P; Haley AP; Starcevic JN; Gaspar L; Petrovic D
Cardiovasc Diabetol; 2015 Apr; 14():42. PubMed ID: 25928419
[TBL] [Abstract][Full Text] [Related]
24. Genetic susceptibility to pre diabetes mellitus and related association with obesity and physical fitness components in Mexican-Mestizos.
Costa-Urrutia P; Abud C; Franco-Trecu V; Colistro V; Rodríguez-Arellano ME; Granados J; Seelaender M
Prim Care Diabetes; 2018 Oct; 12(5):416-424. PubMed ID: 30041843
[TBL] [Abstract][Full Text] [Related]
25. Peroxisome proliferator-activated receptor gamma coactivator 1 alpha promoter polymorphisms are associated with early-onset type 2 diabetes mellitus in the Korean population.
Kim JH; Shin HD; Park BL; Cho YM; Kim SY; Lee HK; Park KS
Diabetologia; 2005 Jul; 48(7):1323-30. PubMed ID: 15937669
[TBL] [Abstract][Full Text] [Related]
26. Gly482Ser polymorphism in the peroxisome proliferator-activated receptor gamma coactivator-1alpha gene is associated with oxidative stress and abdominal obesity.
Weng SW; Lin TK; Wang PW; Chen IY; Lee HC; Chen SD; Chuang YC; Liou CW
Metabolism; 2010 Apr; 59(4):581-6. PubMed ID: 19913841
[TBL] [Abstract][Full Text] [Related]
27. Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis.
Maver A; Medica I; Salobir B; Tercelj-Zorman M; Sabovic M; Petrovic D; Peterlin B
Sarcoidosis Vasc Diffuse Lung Dis; 2008 Sep; 25(1):29-35. PubMed ID: 19070258
[TBL] [Abstract][Full Text] [Related]
28. An exonic peroxisome proliferator-activated receptor-γ coactivator-1α variation may mediate the resting energy expenditure through a potential regulatory role on important gene expression in this pathway.
Mirzaei K; Hossein-nezhad A; Emamgholipour S; Ansar H; Khosrofar M; Tootee A; Alatab S
J Nutrigenet Nutrigenomics; 2012; 5(2):59-71. PubMed ID: 22652814
[TBL] [Abstract][Full Text] [Related]
29. Association of PGC-1alpha polymorphisms with age of onset and risk of Parkinson's disease.
Clark J; Reddy S; Zheng K; Betensky RA; Simon DK
BMC Med Genet; 2011 May; 12():69. PubMed ID: 21595954
[TBL] [Abstract][Full Text] [Related]
30. THE PPARGC1A - GLY482SER POLYMORPHISM (RS8192678) AND THE METABOLIC SYNDROME IN A CENTRAL ROMANIAN POPULATION.
Csép K; Szigeti E; Vitai M; Korányi L
Acta Endocrinol (Buchar); 2017; 13(2):161-167. PubMed ID: 31149168
[TBL] [Abstract][Full Text] [Related]
31. Unraveling Gut Microbiota Signatures Associated with PPARD and PARGC1A Genetic Polymorphisms in a Healthy Population.
Bailén M; Tabone M; Bressa C; Lominchar MGM; Larrosa M; González-Soltero R
Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205333
[TBL] [Abstract][Full Text] [Related]
32. Interaction between peroxisome proliferator-activated receptor gamma polymorphism and obesity on type 2 diabetes in a Chinese Han population.
Lv X; Zhang L; Sun J; Cai Z; Gu Q; Zhang R; Shan A
Diabetol Metab Syndr; 2017; 9():7. PubMed ID: 28123453
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion.
Ling C; Del Guerra S; Lupi R; Rönn T; Granhall C; Luthman H; Masiello P; Marchetti P; Groop L; Del Prato S
Diabetologia; 2008 Apr; 51(4):615-22. PubMed ID: 18270681
[TBL] [Abstract][Full Text] [Related]
34. Association of PGC-1α gene with type 2 diabetes in three unrelated endogamous groups of North-West India (Punjab): a case-control and meta-analysis study.
Sharma R; Matharoo K; Kapoor R; Bhanwer AJS
Mol Genet Genomics; 2018 Apr; 293(2):317-329. PubMed ID: 29063962
[TBL] [Abstract][Full Text] [Related]
35. Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis.
Schillemans T; Tragante V; Maitusong B; Gigante B; Cresci S; Laguzzi F; Vikström M; Richards M; Pilbrow A; Cameron V; Foco L; Doughty RN; Kuukasjärvi P; Allayee H; Hartiala JA; Tang WHW; Lyytikäinen LP; Nikus K; Laurikka JO; Srinivasan S; Mordi IR; Trompet S; Kraaijeveld A; van Setten J; Gijsberts CM; Maitland-van der Zee AH; Saely CH; Gong Y; Johnson JA; Cooper-DeHoff RM; Pepine CJ; Casu G; Leiherer A; Drexel H; Horne BD; van der Laan SW; Marziliano N; Hazen SL; Sinisalo J; Kähönen M; Lehtimäki T; Lang CC; Burkhardt R; Scholz M; Jukema JW; Eriksson N; Åkerblom A; James S; Held C; Hagström E; Spertus JA; Algra A; de Faire U; Åkesson A; Asselbergs FW; Patel RS; Leander K
Front Physiol; 2022; 13():909870. PubMed ID: 35812313
[No Abstract] [Full Text] [Related]
36. The association analysis polymorphism of CDKAL1 and diabetic retinopathy in Chinese Han population.
Liu NJ; Xiong Q; Wu HH; Li YL; Yang Z; Tao XM; Du YP; Lu B; Hu RM; Wang XC; Wen J
Int J Ophthalmol; 2016; 9(5):707-12. PubMed ID: 27275426
[TBL] [Abstract][Full Text] [Related]
37. Genetic variations in PPARD and PPARGC1A determine mitochondrial function and change in aerobic physical fitness and insulin sensitivity during lifestyle intervention.
Stefan N; Thamer C; Staiger H; Machicao F; Machann J; Schick F; Venter C; Niess A; Laakso M; Fritsche A; Häring HU
J Clin Endocrinol Metab; 2007 May; 92(5):1827-33. PubMed ID: 17327385
[TBL] [Abstract][Full Text] [Related]
38. Association of the Gly482Ser PPARGC1A gene variant with different cholesterol outcomes in response to two energy-restricted diets in subjects with excessive weight.
Ramos-Lopez O; Riezu-Boj JI; Milagro FI; Goni L; Cuervo M; Martinez JA
Nutrition; 2018 Mar; 47():83-89. PubMed ID: 29429541
[TBL] [Abstract][Full Text] [Related]
39. Common variation at PPARGC1A/B and change in body composition and metabolic traits following preventive interventions: the Diabetes Prevention Program.
Franks PW; Christophi CA; Jablonski KA; Billings LK; Delahanty LM; Horton ES; Knowler WC; Florez JC;
Diabetologia; 2014 Mar; 57(3):485-90. PubMed ID: 24317794
[TBL] [Abstract][Full Text] [Related]
40. Is there an interaction between PPARD T294C and PPARGC1A Gly482Ser polymorphisms and human endurance performance?
Eynon N; Meckel Y; Alves AJ; Yamin C; Sagiv M; Goldhammer E; Sagiv M
Exp Physiol; 2009 Nov; 94(11):1147-52. PubMed ID: 19666693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
